Major Players in Targeted Cancer Therapies Market Focus on Discovery, Development, and Commercialization of Targeted Small Molecule Medicines
Targeted cancer treatments are specially-formulated drugs or chemicals that specifically block the development and progression of various forms of cancer by interfering directly with specific molecules ("targets"), which are involved in cancer's growth, development, and metastasis. These drugs have been shown to be very effective in the treatment and prevention of cancer. Many players in the targeted cancer therapies market are focused on developing small molecule drugs. In July 2019, Pfizer Inc. acquired Array BioPharma Inc. with the aim to advance breakthrough science for the discovery, development and commercialization of targeted small molecule medicines to treat cancer and other diseases of high unmet need. Similarly, in March 2020, IDEAYA Biosciences, Inc. collaborated with Cancer Research UK and the University of Manchester, UK, to develop small molecule inhibitors of Poly(ADP-ribose) glycohydrolase, a DNA damage response-based synthetic lethality target, for DNA...